Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anqi Ma

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Nature Cell Biology|February 25, 2022
EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesisJun Wang, Xufen Yu, Weida Gong, et al.
Cancer Cell|January 11, 2017
Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk NeuroblastomaVeronica Veschi, Zhihui Liu, Ty C Voss, et al.
Blood|November 15, 2014
Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemiaBowen Xu, Doan M On, Anqi Ma, et al.
Scientific Reports|August 27, 2025
Combinatorial DNMTs and EZH2 inhibition reprograms the H3K27me3 and DNAme-mediated onco-epigenome to suppress multiple myeloma proliferationAlba Atienza Párraga, Patrick Nylund, Klev Diamanti, et al.
Circulation Research|December 14, 2017
VE-Cadherin-Mediated Epigenetic Regulation of Endothelial Gene ExpressionMarco F Morini, Costanza Giampietro, Monica Corada, et al.
Nature Communications|March 31, 2019
Targeting bivalency de-represses Indian Hedgehog and inhibits self-renewal of colorectal cancer-initiating cellsEvelyne Lima-Fernandes, Alex Murison, Tiago da Silva Medina, et al.
Blood|August 7, 2019
PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formationZhihong Ren, Jeong Hyun Ahn, Hequn Liu, et al.
International Immunopharmacology|March 31, 2023
Alteration of the tumor microenvironment by pharmacological inhibition of EZH2 in hepatocellular carcinomaNa Qiang, Junjie Ao, Masato Nakamura, et al.
Elife|May 14, 2019
The dynamic conformational landscape of the protein methyltransferase SETD8Shi Chen, Rafal P Wiewiora, Fanwang Meng, et al.
ACS Chemical Biology|April 26, 2013
An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1Kyle D Konze, Anqi Ma, Fengling Li, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Nature Cell Biology|February 25, 2022
EZH2 noncanonically binds cMyc and p300 through a cryptic transactivation domain to mediate gene activation and promote oncogenesisJun Wang, Xufen Yu, Weida Gong, et al.
Cancer Cell|January 11, 2017
Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk NeuroblastomaVeronica Veschi, Zhihui Liu, Ty C Voss, et al.
Blood|November 15, 2014
Selective inhibition of EZH2 and EZH1 enzymatic activity by a small molecule suppresses MLL-rearranged leukemiaBowen Xu, Doan M On, Anqi Ma, et al.
Scientific Reports|August 27, 2025
Combinatorial DNMTs and EZH2 inhibition reprograms the H3K27me3 and DNAme-mediated onco-epigenome to suppress multiple myeloma proliferationAlba Atienza Párraga, Patrick Nylund, Klev Diamanti, et al.
Circulation Research|December 14, 2017
VE-Cadherin-Mediated Epigenetic Regulation of Endothelial Gene ExpressionMarco F Morini, Costanza Giampietro, Monica Corada, et al.
Nature Communications|March 31, 2019
Targeting bivalency de-represses Indian Hedgehog and inhibits self-renewal of colorectal cancer-initiating cellsEvelyne Lima-Fernandes, Alex Murison, Tiago da Silva Medina, et al.
Blood|August 7, 2019
PHF19 promotes multiple myeloma tumorigenicity through PRC2 activation and broad H3K27me3 domain formationZhihong Ren, Jeong Hyun Ahn, Hequn Liu, et al.
International Immunopharmacology|March 31, 2023
Alteration of the tumor microenvironment by pharmacological inhibition of EZH2 in hepatocellular carcinomaNa Qiang, Junjie Ao, Masato Nakamura, et al.
Elife|May 14, 2019
The dynamic conformational landscape of the protein methyltransferase SETD8Shi Chen, Rafal P Wiewiora, Fanwang Meng, et al.
ACS Chemical Biology|April 26, 2013
An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1Kyle D Konze, Anqi Ma, Fengling Li, et al.
Pageof 6